Acyl-CoA Synthetase Medium-Chain Family Member 1 (ACSM1) (N-Term) Peptide

Details for Product No. ABIN698884, Supplier: Log in to see
Protein Name
  • BUCS1
  • MACS1
  • Acas3
  • Bucs1
  • Macs
  • acyl-CoA synthetase medium-chain family member 1
  • ACSM1
  • Acsm1
Protein Region
Peptide Type
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Specificity The synthetic peptide sequence used to generate the antibody AP9284a was selected from the N-term region of human ACSM1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Background ACSM1 has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). This protein acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy-and 2,3-or 3,4-unsaturated acids (in vitro). This protein functions as GTP-dependent lipoate-activating enzyme that generates the substrate for lipoyltransferase
Restrictions For Research Use only
Storage 4
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Background publications Celis, Gromov, Cabezón, Moreira, Friis, Jirström, Llombart-Bosch, Timmermans-Wielenga, Rank, Gromova: "15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma." in: Molecular & cellular proteomics : MCP, Vol. 7, Issue 10, pp. 1795-809, 2008 (PubMed).

Sullivan, Lin, Tzeng, van den Oord, Perkins, Stroup, Wagner, Lee, Wright, Zou, Liu, Downing, Lieberman, Close: "Genomewide association for schizophrenia in the CATIE study: results of stage 1." in: Molecular psychiatry, Vol. 13, Issue 6, pp. 570-84, 2008 (PubMed).